Loading…
Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort
BACKGROUND Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinica...
Saved in:
Published in: | American journal of hypertension 2014-11, Vol.27 (11), p.1396-1407 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3 |
container_end_page | 1407 |
container_issue | 11 |
container_start_page | 1396 |
container_title | American journal of hypertension |
container_volume | 27 |
creator | Chiang, Heng-Pin Lee, Jia-Jung Chiu, Yi-Wen Tsai, Jer-Chia Hung, Chi-Chih Hwang, Shang-Jyh Chen, Hung-Chun |
description | BACKGROUND
Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship.
METHODS
This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured.
RESULTS
In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria.
CONCLUSIONS
Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients. |
doi_str_mv | 10.1093/ajh/hpu056 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4263936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajh/hpu056</oup_id><sourcerecordid>2306323897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoModlu98QdIQLwpjM13Jl4IutZWLLTQeh2SzJlOlt3JmsxU9t8b2bboTa_OxXnOe154EHpDyQdKDD9xq-Fk2M5EqmdoQY2gjWZMPkcL0hrZaKLoATosZUUIEUrRl-iACc00l2aByvWuTGkdA_6yTqnDVxlKmTNgN3b4cp5C2kDBccTXk7sFzBuBl0NOYz34EbsRdvhrLOAK4Cs3RRin8hGf3sUOxgC4z2mDHb5x8bcboTLLNKQ8vUIvercu8Pp-HqGf305vlufNxeXZ9-XniyZIwqZGhJ6ACmA8c741nhAqqfJdH4LQ3nPdtkY56ZhiQijvFaOy10JT6J02MvAj9Gmfu539BrpQ22W3ttscNy7vbHLR_r8Z42Bv050VTHHDVQ14dx-Q068ZymRXac5j7WwZJ4oz3hpdqeM9FXIqJUP_-IES-1eQrYLsXlCF3_7b6RF9MFKB93sgzdungv4Aw2eahw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2306323897</pqid></control><display><type>article</type><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><source>Oxford Journals Online</source><creator>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</creator><creatorcontrib>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</creatorcontrib><description>BACKGROUND
Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship.
METHODS
This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured.
RESULTS
In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria.
CONCLUSIONS
Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1093/ajh/hpu056</identifier><identifier>PMID: 24727359</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aged ; Antihypertensive Agents - therapeutic use ; Blood pressure ; Blood Pressure - drug effects ; Diabetes ; Disease Progression ; Female ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - mortality ; Hypertension - physiopathology ; Kidney diseases ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - physiopathology ; Kidney Failure, Chronic - therapy ; Male ; Middle Aged ; Original ; Proportional Hazards Models ; Prospective Studies ; Renal Dialysis ; Renal Insufficiency, Chronic - diagnosis ; Renal Insufficiency, Chronic - mortality ; Renal Insufficiency, Chronic - physiopathology ; Renal Insufficiency, Chronic - therapy ; Risk Factors ; Severity of Illness Index ; Systole ; Taiwan ; Time Factors ; Treatment Outcome</subject><ispartof>American journal of hypertension, 2014-11, Vol.27 (11), p.1396-1407</ispartof><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014</rights><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><rights>American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</citedby><cites>FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24727359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiang, Heng-Pin</creatorcontrib><creatorcontrib>Lee, Jia-Jung</creatorcontrib><creatorcontrib>Chiu, Yi-Wen</creatorcontrib><creatorcontrib>Tsai, Jer-Chia</creatorcontrib><creatorcontrib>Hung, Chi-Chih</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><title>American journal of hypertension</title><addtitle>Am J Hypertens</addtitle><description>BACKGROUND
Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship.
METHODS
This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured.
RESULTS
In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria.
CONCLUSIONS
Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</description><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Diabetes</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - mortality</subject><subject>Hypertension - physiopathology</subject><subject>Kidney diseases</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Renal Dialysis</subject><subject>Renal Insufficiency, Chronic - diagnosis</subject><subject>Renal Insufficiency, Chronic - mortality</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Systole</subject><subject>Taiwan</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0895-7061</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kV1rFDEUhoModlu98QdIQLwpjM13Jl4IutZWLLTQeh2SzJlOlt3JmsxU9t8b2bboTa_OxXnOe154EHpDyQdKDD9xq-Fk2M5EqmdoQY2gjWZMPkcL0hrZaKLoATosZUUIEUrRl-iACc00l2aByvWuTGkdA_6yTqnDVxlKmTNgN3b4cp5C2kDBccTXk7sFzBuBl0NOYz34EbsRdvhrLOAK4Cs3RRin8hGf3sUOxgC4z2mDHb5x8bcboTLLNKQ8vUIvercu8Pp-HqGf305vlufNxeXZ9-XniyZIwqZGhJ6ACmA8c741nhAqqfJdH4LQ3nPdtkY56ZhiQijvFaOy10JT6J02MvAj9Gmfu539BrpQ22W3ttscNy7vbHLR_r8Z42Bv050VTHHDVQ14dx-Q068ZymRXac5j7WwZJ4oz3hpdqeM9FXIqJUP_-IES-1eQrYLsXlCF3_7b6RF9MFKB93sgzdungv4Aw2eahw</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Chiang, Heng-Pin</creator><creator>Lee, Jia-Jung</creator><creator>Chiu, Yi-Wen</creator><creator>Tsai, Jer-Chia</creator><creator>Hung, Chi-Chih</creator><creator>Hwang, Shang-Jyh</creator><creator>Chen, Hung-Chun</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20141101</creationdate><title>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</title><author>Chiang, Heng-Pin ; Lee, Jia-Jung ; Chiu, Yi-Wen ; Tsai, Jer-Chia ; Hung, Chi-Chih ; Hwang, Shang-Jyh ; Chen, Hung-Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Diabetes</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - mortality</topic><topic>Hypertension - physiopathology</topic><topic>Kidney diseases</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Renal Dialysis</topic><topic>Renal Insufficiency, Chronic - diagnosis</topic><topic>Renal Insufficiency, Chronic - mortality</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Systole</topic><topic>Taiwan</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiang, Heng-Pin</creatorcontrib><creatorcontrib>Lee, Jia-Jung</creatorcontrib><creatorcontrib>Chiu, Yi-Wen</creatorcontrib><creatorcontrib>Tsai, Jer-Chia</creatorcontrib><creatorcontrib>Hung, Chi-Chih</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiang, Heng-Pin</au><au>Lee, Jia-Jung</au><au>Chiu, Yi-Wen</au><au>Tsai, Jer-Chia</au><au>Hung, Chi-Chih</au><au>Hwang, Shang-Jyh</au><au>Chen, Hung-Chun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort</atitle><jtitle>American journal of hypertension</jtitle><addtitle>Am J Hypertens</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>27</volume><issue>11</issue><spage>1396</spage><epage>1407</epage><pages>1396-1407</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><abstract>BACKGROUND
Systolic blood pressure (SBP) goal for chronic kidney disease (CKD) patients is ≤140mm Hg. However, the SBP target provides no suggested lower limit, and some studies indicate that a lower SBP target may be harmful. We aimed to investigate the J-shaped relationship between SBP and clinical outcomes in CKD patients and the factors that modify this relationship.
METHODS
This prospective observational study enrolled 2,144 CKD stage 3-4 patients between November 2002 and May 2009 and followed them until July 2010 or death. Patients included were also enrolled within the Integrated CKD Care Program for Delaying Dialysis in a medical center and its branch hospital. Demographic, clinical, laboratory, and disease variables at baseline and end of observation were measured.
RESULTS
In diabetic CKD patients, the hazard ratio (HR) at SBP 96-110mm Hg vs. 111-120mm Hg was 2.52 (95% confidence interval (CI) = 1.13-5.58) for cardiovascular outcomes and was 3.14 (95% CI = 1.16-8.49) for renal outcomes. In nondiabetic CKD patients, this J-shaped relationship was not seen. Heavy proteinuria was further found to modify the J-shaped relationship in diabetic CKD patients. The HR for renal outcomes at SBP 96-110mm Hg vs. 111-120mm Hg was 4.07 (95% CI = 1.18-13.99) in diabetic CKD patients with heavy proteinuria vs. 1.72 (95% CI = 0.13-22.5) in those without heavy proteinuria.
CONCLUSIONS
Diabetic CKD patients have a J-shaped relationship between SBP and cardiovascular or renal outcomes, but nondiabetic CKD patients do not. The optimal SBP range might be narrower in the diabetic CKD patients.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>24727359</pmid><doi>10.1093/ajh/hpu056</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-7061 |
ispartof | American journal of hypertension, 2014-11, Vol.27 (11), p.1396-1407 |
issn | 0895-7061 1941-7225 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4263936 |
source | Oxford Journals Online |
subjects | Aged Antihypertensive Agents - therapeutic use Blood pressure Blood Pressure - drug effects Diabetes Disease Progression Female Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - mortality Hypertension - physiopathology Kidney diseases Kidney Failure, Chronic - mortality Kidney Failure, Chronic - physiopathology Kidney Failure, Chronic - therapy Male Middle Aged Original Proportional Hazards Models Prospective Studies Renal Dialysis Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - mortality Renal Insufficiency, Chronic - physiopathology Renal Insufficiency, Chronic - therapy Risk Factors Severity of Illness Index Systole Taiwan Time Factors Treatment Outcome |
title | Systolic Blood Pressure and Outcomes in Stage 3-4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A49%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systolic%20Blood%20Pressure%20and%20Outcomes%20in%20Stage%203-4%20Chronic%20Kidney%20Disease%20Patients:%20Evidence%20from%20a%20Taiwanese%20Cohort&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Chiang,%20Heng-Pin&rft.date=2014-11-01&rft.volume=27&rft.issue=11&rft.spage=1396&rft.epage=1407&rft.pages=1396-1407&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/hpu056&rft_dat=%3Cproquest_pubme%3E2306323897%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-4cf0e6ce9b2ab89b001516bdfcc47bb378896a5a262446bb6215f7471efa795c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2306323897&rft_id=info:pmid/24727359&rft_oup_id=10.1093/ajh/hpu056&rfr_iscdi=true |